- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT07593963
Relation Between Scapular Dyskinesia, Rotator Cuff Strength And Subacromial Space In Asymptomatic Scapular Dyskinesia (ASD)
17. mai 2026 oppdatert av: Aya Mostafa Mohamed Sayed, Cairo University
This study will be conducted to investigate the relationship between scapular dyskinesia and rotator cuff muscle strength and acromiohumeral distance in asymptomatic individuals.
Studieoversikt
Status
Har ikke rekruttert ennå
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
When the scapula moves in an abnormal way, a condition known as scapular dysfunction (SD) occurs, leading to shoulder pain and dysfunction.
It is possible for patients with SD to experience no symptoms at all.
SD symptoms can include a combination of the following anterior shoulder pain, Posterosuperior scapular pain, Superior shoulder pain, shoulder impingement syndrome, rotator cuff dysfunction, and shoulder instability.Things like early scapular elevation, abrupt downward rotation, and a prominent medial edge and inferior angle of the scapula are seen during shoulder motions.
It has been suggested that impaired scapulothoracic musculature function might lead to changes in shoulder kinematics, which in turn can increase the risk of injury.Individuals with SD often experience pathologies such as scapula-humeral rhythm disturbance, glenoid labrum difficulties, glenohumeral instability, rotator cuff syndrome, subacromial impingement syndrome, and glenoid labrum abnormalities.
In individuals suffering from RC tendinopathy, a decline in RC muscle performance is associated with lower health-related quality of life and patient-rated function.
In order to determine which patients with scapular dyskinesis may benefit most from a rehabilitation program aimed at enhancing muscular performance, clinicians may find it useful to gather data on shoulder strength.
A portable dynamometer is an easy, cheap, and valid way to get these kinds of data.
to fill that gap in literature by Finding an association between scapular dyskinesia and the acromiohumeral distance and rotator cuff muscle strength in individuals with asymptomatic scapular dyskinesia
Studietype
Observasjonsmessig
Registrering (Antatt)
51
Kontakter og plasseringer
Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.
Studiekontakt
- Navn: Aya mostafa, master
- Telefonnummer: 01142667586
- E-post: ayaphysicaltherapy2020@gmail.com
Deltakelseskriterier
Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Voksen
Tar imot friske frivillige
Nei
Prøvetakingsmetode
Ikke-sannsynlighetsprøve
Studiepopulasjon
Fifty-one subjects with asymptomatic scapular dyskinesia, their ages ranging from eighteen to forty years.
subjects showed an opposite result on lateral scapular slide test and with a visual-based palpation method
Beskrivelse
Inclusion Criteria:
- Both genders.
- Those experiencing asymptomatic scapular dyskinesia
- The average age of the population ranges from eighteen to forty years.
- Individuals who showed appositive result on lateral scapular slide test and with a visual-based palpation method
- Type 2 and 3 scapular dyskinesia
Exclusion Criteria:
- any type of injury or pain affecting the neck, shoulders, or cervical region
- Participating in any form of formal athletic training or fitness program with their express written approval
- If they had previously suffered an injury to their upper limbs, such as a dislocation, fracture, or strain
Studieplan
Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.
Hvordan er studiet utformet?
Designdetaljer
Kohorter og intervensjoner
Gruppe / Kohort |
Intervensjon / Behandling |
|---|---|
|
asymptomatic scapular dyskinesia group
fifty-one asymptomatic scapular dyskinesia subjects will be included
|
From both genders, fifty-one asymptomatic scapular dyskinesia subjects were included in this group.
their ages from eighteen to forty years.
Subjects showed an opposite result on the lateral scapular slide test.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
subacromial space
Tidsramme: up to one day
|
The subacromial space will be measured by ultrasonography device with mm or cm. it was defined as the linear perpendicular distance between the top surface of the humeral head and the lower surface of the acromion
|
up to one day
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
shoulder internal rotator muscles strength
Tidsramme: up to one day
|
shoulder internal rotator muscles strength will be measured by active force 2 device
|
up to one day
|
|
shoulder external rotator muscles strength
Tidsramme: up to one day
|
shoulder external rotator muscles strength will be measured by the Active Force 2 device
|
up to one day
|
|
scapular dyskinesis
Tidsramme: up to one day
|
lateral scapular slide test (LSST) will be used to assess scapular dyskinesis.
examined the distance between the scapular inferior angle and the corresponding spinous process in three different positions using the lateral scapular slide test (LSST) to evaluate scapular stability in both the right and left scapula.
The subject's arms were relaxed at his sides, lying on his hips, with his shoulders internally rotated and abducted 45 degrees, and fully internally rotated and abducted 90 degrees.Kibler has stated that a 1.5 cm discrepancy on both sides should be considered abnormal scapular asymmetry.
|
up to one day
|
Samarbeidspartnere og etterforskere
Det er her du vil finne personer og organisasjoner som er involvert i denne studien.
Sponsor
Studierekorddatoer
Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.
Studer hoveddatoer
Studiestart (Antatt)
20. mai 2026
Primær fullføring (Antatt)
20. juli 2026
Studiet fullført (Antatt)
20. juli 2026
Datoer for studieregistrering
Først innsendt
12. mai 2026
Først innsendt som oppfylte QC-kriteriene
12. mai 2026
Først lagt ut (Faktiske)
18. mai 2026
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
20. mai 2026
Siste oppdatering sendt inn som oppfylte QC-kriteriene
17. mai 2026
Sist bekreftet
1. mai 2026
Mer informasjon
Begreper knyttet til denne studien
Andre studie-ID-numre
- P.T.REC/012/006147
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Nei
Studerer et amerikansk FDA-regulert enhetsprodukt
Nei
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .